Product Information
APREPITANT 40 MG CAPSULE is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $39.7598 per EA under NDC 68462058385. Its NADAC has been published 419 times since Jun 20, 2018.
Strength
40 mg/1
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462058385
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
APREPITANTApproval Type
Generic (ANDA)
FDA Application
ANDA207777On Market Since
10/12/2017
Pharmacological Classes
Price Statistics
The NADAC for APREPITANT 40 MG CAPSULE has been published 419 times since Jun 20, 2018, and over the history we have for it it has declined 47.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $39.7598 per EA |
|---|---|
| All-time high | $83.7756 (Aug 12, 2020) |
| All-time low | $34.4783 (Nov 20, 2024) |
| 52-week high | $50.0851 |
| 52-week low | $38.1856 |
| Median price | $66.7486 |
| Average price | $63.5922 |
| Largest weekly change | +42.7% (Feb 22, 2023) |
| Weeks tracked | 419 |
| Tracking since | Jun 20, 2018 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of APREPITANT 40 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for APREPITANT 40 MG CAPSULE, manufactured by Glenmark Pharmaceuticals Inc., USA, is $39.7598 per EA (NDC 68462058385), effective Jun 24, 2026.
How has the price of APREPITANT 40 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for APREPITANT 40 MG CAPSULE has declined 47.6%. It has been tracked across 419 weekly CMS publications since Jun 20, 2018.
What are the highest and lowest recorded NADAC prices for APREPITANT 40 MG CAPSULE?
Since Jun 20, 2018, the NADAC for APREPITANT 40 MG CAPSULE has ranged from a low of $34.4783 (Nov 20, 2024) to a high of $83.7756 (Aug 12, 2020), with a median of $66.7486 per EA.
Are there cheaper alternatives to APREPITANT 40 MG CAPSULE?
2 NADAC-published products share the same active ingredient, strength, and dosage form as APREPITANT 40 MG CAPSULE, but none are currently priced below it.
Who manufactures APREPITANT 40 MG CAPSULE?
APREPITANT 40 MG CAPSULE (NDC 68462058385) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.
Related Drugs
Same classification